Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated

B J Czerniecki1, C Carter, L Rivoltini

  • 1Department of Surgery, University of Pennsylvania Medical Center, Philadelphia 19104, USA.

Insights

Calcium ionophore (CI) rapidly converts human monocytes and immature dendritic cells (iDC) into activated dendritic cells (DC). This method efficiently generates autologous antigen-presenting cells (APC) for T cell sensitization strategies.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Peripheral blood contains immature dendritic cells (iDC) and monocytes, differing in CD14 expression.
  • Both cell types are crucial for immune responses but require activation for optimal function.

Purpose of the Study:

  • To investigate the potential of calcium ionophore (CI) to induce monocyte and iDC activation.
  • To evaluate the efficacy of CI-treated cells as antigen-presenting cells (APC) for T cell sensitization.

Main Methods:

  • Isolation of myeloid origin mononuclear cells (MOMC), including monocytes and iDC, using leukapheresis and elutriation.
  • Treatment of cells with calcium ionophore (CI), recombinant human granulocyte-monocyte colony-stimulating factor (rhGM-CSF), or endotoxin.
  • Immunophenotypic analysis (CD14, CD83, MHC, costimulatory molecules) and morphologic assessment.
  • Assessment of T cell sensitization capacity using keyhole limpet hemocyanin (KLH) and MART-1 peptide.

Main Results:

  • CI treatment rapidly induced dendritic cell (DC) morphology, down-regulated CD14, and upregulated MHC and costimulatory molecules in monocytes and iDC.
  • CI treatment led to de novo CD83 expression, an activation marker, within 20 hours.
  • CI-treated monocytes and iDC demonstrated enhanced T cell-sensitizing efficiency, enabling CD4+ and CD8+ T cell sensitization in a single stimulation.

Conclusions:

  • Circulating monocytes and iDC can be effectively induced into activated DC by CI treatment.
  • CI provides a rapid and consistent method for generating large numbers of potent, autologous APC for T cell-based immunotherapies.

Related Concept Videos